These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23628473)

  • 1. The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism.
    Huang J; Das SK; Jha P; Al Zoughbi W; Schauer S; Claudel T; Sexl V; Vesely P; Birner-Gruenberger R; Kratky D; Trauner M; Hoefler G
    Biochim Biophys Acta; 2013 Oct; 1831(10):1555-65. PubMed ID: 23628473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
    Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
    Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
    J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
    Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome.
    Belfort R; Berria R; Cornell J; Cusi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):829-36. PubMed ID: 20061429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARα/AMPK/FoxO1/ATGL pathway.
    Chen WL; Chen YL; Chiang YM; Wang SG; Lee HM
    Biochem Pharmacol; 2012 Aug; 84(4):522-31. PubMed ID: 22687626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic
    Lee YH; Jang HJ; Kim S; Choi SS; Khim KW; Eom HJ; Hyun J; Shin KJ; Chae YC; Kim H; Park J; Park NH; Woo CY; Hong CH; Koh EH; Nam D; Choi JH
    Elife; 2021 Dec; 10():. PubMed ID: 34964438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
    PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice.
    Jeong S; Kim M; Han M; Lee H; Ahn J; Kim M; Song YH; Shin C; Nam KH; Kim TW; Oh GT; Yoon M
    Metabolism; 2004 May; 53(5):607-13. PubMed ID: 15131765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice.
    Oosterveer MH; Grefhorst A; van Dijk TH; Havinga R; Staels B; Kuipers F; Groen AK; Reijngoud DJ
    J Biol Chem; 2009 Dec; 284(49):34036-44. PubMed ID: 19801551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy.
    Yoo J; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Metabolism; 2021 Jul; 120():154798. PubMed ID: 33984335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
    Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
    Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice.
    Jeong S; Han M; Lee H; Kim M; Kim J; Nicol CJ; Kim BH; Choi JH; Nam KH; Oh GT; Yoon M
    Metabolism; 2004 Oct; 53(10):1284-9. PubMed ID: 15375783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice.
    Li J; Bi L; Hulke M; Li T
    J Biol Chem; 2014 Aug; 289(32):22437-49. PubMed ID: 24986865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARα levels.
    Chang CJ; Tzeng TF; Liou SS; Chang YS; Liu IM
    Planta Med; 2011 Nov; 77(17):1876-82. PubMed ID: 21728151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.
    Goto T; Hirata M; Aoki Y; Iwase M; Takahashi H; Kim M; Li Y; Jheng HF; Nomura W; Takahashi N; Kim CS; Yu R; Seno S; Matsuda H; Aizawa-Abe M; Ebihara K; Itoh N; Kawada T
    J Biol Chem; 2017 Jun; 292(22):9175-9190. PubMed ID: 28404815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.